Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-25 @ 3:38 AM
NCT ID:
NCT00299702
Eligibility Criteria:
Inclusion Criteria:
* Patients with diagnosis of schizophrenia
* Patient has had at least 2 psychotic relapses in the two years prior to study entry
* patient is not adequately benefiting from their current antipsychotic medication
Exclusion Criteria:
* Patients that have been hospitalized or had major medication changes within 2 months of study entry
* Patients currently experiencing, or who have experienced worsening of disease symptoms within 2 months of study entry
* Patients currently using clozapine or carbamazepine
* Patients who have undergone electroconvulsive therapy or depot antipsychotic treatment within 6 months prior to study entry
* pregnant or breast-feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00299702
Study Brief:
Protocol Section:
NCT00299702